FDA Inspection
LifeSouth Community Blood Centers, Inc.LifeSouth Community Blood Centers, Inc. – FDA Inspection, Jun 25, 2018
Record Details
This FDA Inspection record concerns LifeSouth Community Blood Centers, Inc., with an inspection on June 25, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 989d0119-e678-43fb-83bb-1ec7e242439c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1056540
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of LifeSouth Community Blood Centers, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| April 7, 2025 | Not classified | New Orleans District Office | |
| December 15, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| January 8, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 21, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 19, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for LifeSouth Community Blood Centers, Inc.
- FDA Inspection 1267915 - 2025-04-07
- FDA Inspection 1194267 - 2022-12-15
- FDA Inspection 953949 - 2016-01-08
- FDA Inspection 892032 - 2014-08-21
- FDA Inspection 792009 - 2012-07-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.